• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The optimal TSH level necessary for successful radioiodine ablation of differentiated thyroid carcinoma, as well as the time to reach this level, is a work in progress.

作者信息

Lawal Ismaheel O, Vorster Mariza, Ankrah Alfred O, Sathekge Mike M

机构信息

Department of Nuclear Medicine, University of Pretoria and Steve Biko Academic Hospital, Private Bag X169, Pretoria, 0001, South Africa.

Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

出版信息

Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1270-1271. doi: 10.1007/s00259-018-3999-y. Epub 2018 Mar 29.

DOI:10.1007/s00259-018-3999-y
PMID:29594409
Abstract
摘要

相似文献

1
The optimal TSH level necessary for successful radioiodine ablation of differentiated thyroid carcinoma, as well as the time to reach this level, is a work in progress.分化型甲状腺癌放射性碘消融成功所需的最佳促甲状腺激素（TSH）水平以及达到该水平的时间仍在研究中。
Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1270-1271. doi: 10.1007/s00259-018-3999-y. Epub 2018 Mar 29.
2
Higher preablative serum thyroid-stimulating hormone level predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma.较高的消融前血清促甲状腺激素水平可预测分化型甲状腺癌患者放射性碘消融的有效性。
Nucl Med Commun. 2017 Mar;38(3):222-227. doi: 10.1097/MNM.0000000000000640.
3
Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma: a large randomized clinical trial.分化型甲状腺癌患者术后残留甲状腺组织消融中低剂量与高剂量放射性碘的比较：一项大型随机临床试验
Nucl Med Commun. 2012 Mar;33(3):275-82. doi: 10.1097/MNM.0b013e32834e306a.
4
Radioactive iodine lobe ablation as an alternative to completion thyroidectomy for follicular carcinoma of the thyroid.放射性碘叶消融术作为甲状腺滤泡癌甲状腺全切术的替代方案。
Thyroid. 2002 Nov;12(11):989-96. doi: 10.1089/105072502320908321.
5
[Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].[分化型甲状腺癌的诊断、治疗及随访]
Wien Med Wochenschr. 2005 Oct;155(19-20):429-35. doi: 10.1007/s10354-005-0219-8.
6
Follow-up of differentiated thyroid carcinoma.分化型甲状腺癌的随访
Minerva Endocrinol. 2004 Dec;29(4):161-74.
7
Postsurgical thyroid remnant estimation by (⁹⁹m) Tc-pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma.（⁹⁹m）Tc-过锝酸盐闪烁显像术对甲状腺术后残余甲状腺组织的估计预测分化型甲状腺癌患者放射性碘消融的效果。
Head Neck. 2011 Apr;33(4):552-6. doi: 10.1002/hed.21490. Epub 2010 Sep 7.
8
A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation.重组人促甲状腺素作为放射性碘甲状腺残余组织消融术前准备的有效性回顾性研究。
J Nucl Med. 2002 Nov;43(11):1482-8.
9
The efficacy of radioiodine remnant ablation for differentiated thyroid carcinoma patients with an incomplete thyroidectomy.放射性碘残留消融术对甲状腺次全切除术后分化型甲状腺癌患者的疗效。
Q J Nucl Med Mol Imaging. 2016 Sep;60(3):280-4. Epub 2014 Sep 5.
10
Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.重组人促甲状腺素辅助 131I 消融术前甲状腺球蛋白测定在检测分化型甲状腺癌转移灶中的应用
Clin Endocrinol (Oxf). 2008 Oct;69(4):659-63. doi: 10.1111/j.1365-2265.2008.03244.x. Epub 2008 Mar 18.

本文引用的文献

1
Could short thyroid hormone withdrawal be an effective strategy for radioiodine remnant ablation in differentiated thyroid cancer patients?短程甲状腺激素抑制治疗在分化型甲状腺癌患者放射性碘清甲治疗中的作用
Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1218-1223. doi: 10.1007/s00259-018-3955-x. Epub 2018 Feb 19.
2
Higher preablative serum thyroid-stimulating hormone level predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma.较高的消融前血清促甲状腺激素水平可预测分化型甲状腺癌患者放射性碘消融的有效性。
Nucl Med Commun. 2017 Mar;38(3):222-227. doi: 10.1097/MNM.0000000000000640.
3
Is Very High Thyroid Stimulating Hormone Level Required in Differentiated Thyroid Cancer for Ablation Success?
分化型甲状腺癌消融成功是否需要非常高的促甲状腺激素水平？
Mol Imaging Radionucl Ther. 2016 Jun 5;25(2):79-84. doi: 10.4274/mirt.88598.
4
In Patients With Low- to Intermediate-Risk Thyroid Cancer, a Preablative Thyrotropin Level of 30 μIU/mL Is Not Adequate to Achieve Better Response to 131I Therapy.对于低危到中危甲状腺癌患者，促甲状腺激素（TSH）水平达到 30 μIU/mL 并不足以实现更好的 131I 治疗反应。
Clin Nucl Med. 2016 Jun;41(6):454-8. doi: 10.1097/RLU.0000000000001167.
5
Endogenous TSH levels at the time of I ablation do not influence ablation success, recurrence-free survival or differentiated thyroid cancer-related mortality.I消融时的内源性促甲状腺激素水平不影响消融成功率、无复发生存率或分化型甲状腺癌相关死亡率。
Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):224-231. doi: 10.1007/s00259-015-3223-2. Epub 2015 Oct 23.
6
Homeostatic equilibria between free thyroid hormones and pituitary thyrotropin are modulated by various influences including age, body mass index and treatment.游离甲状腺激素与垂体促甲状腺激素之间的稳态平衡受多种因素调节，包括年龄、体重指数和治疗。
Clin Endocrinol (Oxf). 2014 Dec;81(6):907-15. doi: 10.1111/cen.12527. Epub 2014 Jul 7.
7
The thyroid axis 'setpoints' are significantly altered after long-term suppressive LT4 therapy.长期抑制性左甲状腺素（LT4）治疗后，甲状腺轴的“设定点”会发生显著改变。
Horm Metab Res. 2014 Oct;46(11):794-9. doi: 10.1055/s-0034-1375678. Epub 2014 May 27.
8
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.美国甲状腺协会修订的甲状腺结节和分化型甲状腺癌患者管理指南。
Thyroid. 2009 Nov;19(11):1167-214. doi: 10.1089/thy.2009.0110.
9
Measurement of serum TSH and thyroid hormones in the management of treatment of thyroid carcinoma with radioiodine.血清促甲状腺激素和甲状腺激素检测在放射性碘治疗甲状腺癌中的应用
Br J Radiol. 1977 Nov;50(599):799-807. doi: 10.1259/0007-1285-50-599-799.